Albumin improves stratification in the low IPI risk patients with diffuse large B-cell lymphoma

No abstract is available for this paper.

• Publication year

  2020

• Venue

  International journal of hematology

• Publication date

  2020-01-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12185-020-02818-9PMID 31993938
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic impact of pretreatment albumin to globulin ratio in patients with diffuse large B-cell lymphoma treated with R-CHOP.

  2018cited by this paper
• Cancer Immunotherapy in Diffuse Large B-Cell Lymphoma

  2018cited by this paper
• The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP

  2017cited by this paper
• A Host-Dependent Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma.

  2017cited by this paper
• Glasgow prognostic score is superior to other inflammation-based scores in predicting survival of diffuse large B-cell lymphoma

  2017cited by this paper
• Low prognostic nutritional index predicts poor outcome in diffuse large B-cell lymphoma treated with R-CHOP

  2016cited by this paper
• Serum albumin level at diagnosis of diffuse large B‐cell lymphoma: an important simple prognostic factor

  2016cited by this paper
• Serum albumin as a stable predictor of prognosis during initial treatment in patients with diffuse large B cell lymphoma

  2015cited by this paper
• A modified scoring of the NCCN‐IPI is more accurate in the elderly and is improved by albumin and β2‐microglobulin

  2015cited by this paper
• Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab era

  2014cited by this paper
• Low lymphocyte-to-monocyte ratio predicts unfavorable prognosis in non-germinal center type diffuse large B-cell lymphoma.

  2014cited by this paper
• The Glasgow Prognostic Score as a significant predictor of diffuse large B cell lymphoma treated with R-CHOP in China

  2014cited by this paper
• Prognosis in diffuse large B‐cell lymphoma

  2013cited by this paper
• Diffuse large B-cell lymphoma: current strategies and future directions.

  2012cited by this paper
• Prognostic factors in patients with diffuse large B cell lymphoma: Before and after the introduction of rituximab

  2008cited by this paper
• The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.

  2007cited by this paper
• WHO classification of tumours of haematopoietic and lymphoid tissues Chronic myeloproliferative diseases Myelodysplastic / myeloproliferative diseases Chronic myelogenous leukaemia ( CML ) Chronic myelomonocytic leukaemia ( CMML ) Chronic neutrophilic leukaemia Atypical chronic myeloid leukaemia Chr

  2007cited by this paper
• WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues

  2007cited by this paper
• Clinical Trials and Observations

  2005cited by this paper
• Albumin Concentrations Are Primarily Determined by the Body Cell Mass and the Systemic Inflammatory Response in Cancer Patients With Weight Loss

  2001cited by this paper
• Inflammation and cancer: back to Virchow?

  2001cited by this paper
• Transcapillary escape rate of albumin positively correlates with plasma albumin concentration in acute but not in chronic inflammatory disease.

  1994cited by this paper
• A predictive model for aggressive non-Hodgkin's lymphoma.

  1993cited by this paper
• Tumor necrosis factor-alpha inhibits albumin gene expression in a murine model of cachexia.

  1990cited by this paper
• Tumor necrosis factor-mediated hypoalbuminemia in rabbits.

  1988cited by this paper

• Evaluation of outcome and safety profile in high-dose BEAM and Benda-EAM chemotherapy with subsequent autologous stem cell transplantation in lymphoma patients

  2024cites this paper
• Association between serum albumin levels and survival in elderly patients with diffuse large B-cell lymphoma: a single-center retrospective study

  2023cites this paper
• Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study

  2023cites this paper
• Prognostic value of lactate dehydrogenase, serum albumin and the lactate dehydrogenase/albumin ratio in patients with diffuse large B-cell lymphoma

  2023cites this paper
• Baseline serum albumin levels for predicting progression-free survival in patients with non-hodgkin lymphoma: A single-center prospective study in Syria

  2023cites this paper
• Validation and modification of simplified Geriatric Assessment and Elderly Prognostic Index: Effective tools for older patients with diffuse large B‐cell lymphoma

  2023cites this paper
• Pretreatment C-reactive protein-to-albumin ratio predicts clinical outcomes in patients with peripheral T-cell lymphoma

  2022cites this paper
• TRAIL Score: A Simple Model to Predict Immunochemotherapy Tolerability in Patients With Diffuse Large B-Cell Lymphoma

  2022cites this paper
• Impact of hypoalbuminemia on the prognosis of relapsed/refractory B‐cell lymphoma treated with axicabtagene ciloleucel

  2021cites this paper
• Prognostic Role of Serum Albumin Level in Patients with Lymphoma Undergoing Autologous Stem Cell Transplantation

  2021cites this paper
• Bioavailable 25(OH)D level is associated with clinical outcomes of patients with diffuse large B-cell lymphoma: An exploratory study.

  2020cites this paper
• Consecutive Hypoalbuminemia Predicts Inferior Outcome in Patients With Diffuse Large B-Cell Lymphoma

  2020cites this paper